These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 112366)

  • 81. Minimum bactericidal concentrations in conventional and two other techniques.
    Rahman M
    J Antimicrob Chemother; 1981 Dec; 8(6):500-2. PubMed ID: 6801004
    [No Abstract]   [Full Text] [Related]  

  • 82. [Example for testing cleaning agents and disinfectants as to probable usefulness (author's transl)].
    Ruschke R
    Zentralbl Bakteriol Orig B; 1974 Feb; 158(5):486-93. PubMed ID: 4208766
    [No Abstract]   [Full Text] [Related]  

  • 83. Quality control limits for microdilution susceptibility tests with norfloxacin.
    Barry AL; Gavan TL; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    J Clin Microbiol; 1987 Jan; 25(1):165-6. PubMed ID: 3098779
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [In vitro antibacterial activity of doxycycline and minocycline (author's transl)].
    Yokozawa M; Nakagawa K
    Jpn J Antibiot; 1975 Aug; 28(4):600-4. PubMed ID: 1099270
    [No Abstract]   [Full Text] [Related]  

  • 85. Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora.
    Bartlett JG; Bustetter LA; Gorbach SL; Onderdonk AB
    Antimicrob Agents Chemother; 1975 Jan; 7(1):55-7. PubMed ID: 1094945
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Bacteriological studies on doxycycline (Bonnamycin 'Cipan') (author's transl)].
    Miyamura S; Ochiai H; Terao M
    Jpn J Antibiot; 1976 May; 29(5):580-4. PubMed ID: 933344
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The fundamental and clinical studies on PT-122M (doxycycline) in the otorhinolaryngological field (author's transl)].
    Iwasawa T
    Jpn J Antibiot; 1975 Aug; 28(4):584-94. PubMed ID: 808657
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
    Nelson ML; Park BH; Levy SB
    J Med Chem; 1994 Apr; 37(9):1355-61. PubMed ID: 8176712
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A comparative investigation of the bactericidal and fungicidal effects of three phenolic disinfectants.
    Hegna IK
    J Appl Bacteriol; 1977 Oct; 43(2):177-81. PubMed ID: 412825
    [No Abstract]   [Full Text] [Related]  

  • 90. Retention of antimicrobial activity after reconstitution of doxycycline gel.
    Dennis M; Wilson T; Woodward T
    J Vet Dent; 2012; 29(2):84-7. PubMed ID: 23008856
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Application of minocycline for intravenous drip in urological field (author's transl)].
    Ishigami J; Mita T; Tanikaze S; Kataoka N
    Jpn J Antibiot; 1974 Jun; 27(3):307-14. PubMed ID: 4140245
    [No Abstract]   [Full Text] [Related]  

  • 92. Antibacterial activity of a new thiatetracycline antibiotic, thiacycline, in comparison with tetracycline, doxycycline and minocycline.
    Russell AD; Ahonkhai I
    J Antimicrob Chemother; 1982 Jun; 9(6):445-9. PubMed ID: 7050073
    [No Abstract]   [Full Text] [Related]  

  • 93. [Antimicrobial and membranolytic activities of anti-burn drug fenozan].
    Petrykina ZM; Polin AN; Plekhanova LG; Ershov VV; Petrov IV
    Antibiot Khimioter; 1992 Mar; 37(3):15-7. PubMed ID: 1514860
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 5-Arylaminopyrimidines.
    Gerns FR; Perrotta A; Hitchings GH
    J Med Chem; 1966 Jan; 9(1):108-15. PubMed ID: 4959880
    [No Abstract]   [Full Text] [Related]  

  • 95. HAIR AS A RESERVOIR OF STAPHYLOCOCCI.
    SUMMERS MM; LYNCH PF; BLACK T
    J Clin Pathol; 1965 Jan; 18(1):13-5. PubMed ID: 14247696
    [TBL] [Abstract][Full Text] [Related]  

  • 96. "Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides.
    Barden TC; Buckwalter BL; Testa RT; Petersen PJ; Lee VJ
    J Med Chem; 1994 Sep; 37(20):3205-11. PubMed ID: 7932547
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Mechanism of tetracycline (TC) and chloramphenicol (CP) resistant R factor of Pseudomonas aeruginosa].
    Ohara Y; Sei S; Kono M
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):190. PubMed ID: 814345
    [No Abstract]   [Full Text] [Related]  

  • 98. The inter-relationship of tetracycline resistance, decynoly-N-acetyl cysteamine and membrane fatty acid composition in Escherichia coli.
    Ringrose PS; Higgins JE
    J Antibiot (Tokyo); 1974 Nov; 27(11):833-7. PubMed ID: 4616028
    [No Abstract]   [Full Text] [Related]  

  • 99. [Intergenus cell fusion between L-form of Pseudomonas aeruginosa and Escherichia coli].
    Kurono M
    Osaka Daigaku Shigaku Zasshi; 1985 Dec; 30(2):284-95. PubMed ID: 3938811
    [No Abstract]   [Full Text] [Related]  

  • 100. Letter: Effect of minocycline on tetracycline-resistant Staphylococcus aureus.
    Leigh DA; Simmons K
    Lancet; 1974 May; 1(7864):1006. PubMed ID: 4133636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.